Table 10.
Physiological Measures
| |
Baseline |
Week 8 |
Week 10 |
Week 13 |
Week 21a |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD)/time | Placebo | Zinc_1 | Zinc_2 | Placebo | Zinc_1 | Zinc_2 | Placebo | Zinc_1 | Zinc_2 | Placebo | Zinc_1 | Zinc_2 | Placebo | Zinc_1 | Zinc_2 |
| Weight | 36.7 (12.1) | 36.8 (13.8) | 32.4 (8.5) | 37.6 (12.3) | 39.2 (14.5) | 33.2 (8.9) | 37.4 (11.8) | 38.4 (14.3) | 32.8 (8.7) | 37.4 (11.7) | 37.4 (14.6) | 32.5 (8.5) | 37.3(11.8) | 37.0 (12.4) | 30.0 (7.0) |
| Heart rate | 83.5 (15.0) | 82.5 (12.8) | 85.5 (8.7) | 83.1 (12.1) | 84.21 (8.2) | 85.0 (7.6) | 82.6 (12.4) | 84.1 (10.6) | 83.3 (6.8) | 90.0 (13.8) | 86.4 (13.6) | 87.3 (8.9) | 90.9 (13.6) | 82.6 (8.6) | 88.6 (8.8) |
| Systolic pressure | 104.7 (9.4) | 105.4 (13.8) | 102.0 (7.8) | 105.5 (9.3) | 104.6 (12.4) | 100.2 (11.2) | 106.7 (8.7) | 108.2 (13.9) | 106.5 (10.0) | 102.8 (10.7) | 103.1 (14.3) | 102.9 (8.2) | 99.8 (12.0) | 105.2 (10.4) | 96.9 (8.8) |
| Diastolic pressure | 67.8 (8.0) | 67.5 (10.0) | 66.5 (7.5) | 68.2 (7.8) | 69.9 (11.2) | 65.3 (6.2) | 71.1 (8.4) | 69.8 (13.0) | 70.0 (6.0) | 65.7 (7.4) | 66.8 (9.2) | 67.0 (8.2) | 62.9 (7.4) | 68.9 (8.7) | 62.0 (8.3) |
a
At week 21, “Placebo” means 13 weeks of placebo and 8 weeks of zinc compared with 21 weeks of zinc for the others. All also received amphetamine after week 8.